Multi-Organ Protective Effects of Curcumin Nanoparticles on Drug-Induced Acute Myocardial Infarction in Rats with Type 1 Diabetes Mellitus

• Published in: Applied sciences Vol. 11; no. 12; p. 5497
• Main Authors: Boarescu, Paul-Mihai, Boarescu, Ioana, Bulboacă, Adriana Elena, Bocșan, Ioana Corina, Pop, Raluca Maria, Gheban, Dan, Râjnoveanu, Ruxandra-Mioara, Râjnoveanu, Armand, Roşian, Ştefan Horia, Buzoianu, Anca Dana, Bolboacă, Sorana D.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.06.2021
• Subjects: Alanine; Alanine transaminase; Alzheimer's disease; Animals; Aspartate transaminase; Bioavailability; Body weight; cardio-protection; Cardiomyocytes; Cardiovascular disease; Clinical trials; Creatinine; Curcumin; Diabetes; Diabetes mellitus; Diabetes mellitus (insulin dependent); Drug dosages; Enlargement; Experiments; Glucose; Heart attacks; hepatoprotection; Insulin resistance; Isoproterenol; Kidneys; Lipids; Liver; Metabolism; Mortality; Myocardial infarction; Nanoparticles; nanoparticules; nephroprotection; Parameters; Pharmaceuticals; Pretreatment; Prolongation; Serum levels; Streptozocin; Transaminase; Urea
• ISSN: 2076-3417; 2076-3417
• DOI: 10.3390/app11125497

The objectives of this study were to investigate the cardio-protective, hepatoprotective and nephroprotective effects of curcumin nanoparticle (NC) pretreatment compared to conventional curcumin (CC) on acute myocardial infarction (AMI) in rats with type 1 diabetes mellitus (T1DM). Fifty-six Wister Bratislava rats were divided into eight groups. The first four groups—C (control group), AMI (group with AMI), T1DM (group with T1DM), and T1DM-AMI (group with T1DM and AMI)—received only saline (S) during the whole experiment. Two groups—S-T1DM-CC-AMI and S-T1DM-NC-AMI—were pretreated with S before T1DM induction. The S-T1DM-CC-AMI group received CC (200 mg/Kg bw (bw—body weight)) after T1DM induction, while the S-T1DM-NC-AMI group received NC (200 mg/Kg bw) after T1DM induction. the CC-T1DM-CC-AMI group received CC (200 mg/Kg bw) during the whole experiment. Similarly, the NC-T1DM-NC-AMI group received NC (200 mg/Kg bw) over the entire experiment. T1DM was induced on day 7 using a single dose of streptozotocin (STZ). AMI was induced with isoproterenol (ISO) on day 22. Both curcumin formulations, CC and NC, prevented the following electrocardiographic changes: prolongation of the QRS complex, enlargement of QT and QTc intervals, and ST-segment elevation. Glucose levels and lipid profile parameters were reduced up to 1.9 times, while C-peptide serum levels were increased up to 1.6 times in groups that received CC or NC. Liver function parameters (aspartate transaminase, alanine transaminase) and kidney function parameters (creatinine, urea) were reduced 4.8 times, and histological changes of liver and kidney tissue were improved by CC or NC administration. Pretreatment with NC proved significantly higher cardioprotective, hepatoprotective and nephroprotective effects in the case of AMI in T1DM.